Lidocaine Hydrochloride Injection, Solution
Product Images NDC 0409-9137

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 0409-9137). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Lidocaine Hydrochloride (Lidocaine Hydrochloride 01)

Chemical structure diagram of Lidocaine Hydrochloride, showing the aromatic ring with two methyl groups, an amide linkage, a diethylamino group, hydrochloride, and a water molecule. The structure depicts the molecular arrangement of the active ingredient Lidocaine Hydrochloride.*

FDA Label Image

Logo (Lidocaine Hydrochloride 02)

FDA Label Image

Label Ndc 0409-4903-34 (Lidocaine Hydrochloride 03)

Label of Lidocaine Hydrochloride 2% Injection, USP, 100 mg/5 mL (20 mg/mL) single-dose vial. Distributed by Hospira, Inc., Lake Forest, IL. The label includes lot and expiration date placeholders, a dosage scale in mg and mL, and states the product is sterile, nonpyrogenic, for intravenous use in cardiac arrhythmias, and contains no preservatives.*

FDA Label Image

Principal Display Panel (100 mg/5 mL Syringe Carton)

Label for Lidocaine Hydrochloride Injection, USP 2%, 100 mg/5 mL (20 mg/mL) by Hospira, Inc. It is a 5 mL glass syringe intended for intravenous use in treating cardiac arrhythmias. The label includes usage instructions, warnings, and manufacturing details, with visual guides for aseptic technique and vial handling. The product is marked Rx only and made in Spain.*

FDA Label Image

Label Ndc 0409-4904-34 (Lidocaine Hydrochloride 05)

Label for 1% Lidocaine Hydrochloride Injection, USP 50 mg/5 mL (10 mg/mL) single-dose vial. The label indicates a 5 mL volume and includes dosing information, lot and expiration placeholders, and the labeler Hospira, Inc., located in Lake Forest, IL. The product is sterile and intended for intravenous use in cardiac arrhythmias.*

FDA Label Image

Principal Display Panel (50 mg/5 mL Syringe Carton)

Lidocaine HCl Injection, USP 1% (50 mg/5 mL or 10 mg/mL) in a 5 mL unit dose glass syringe with male luer lock adapter and 20-gauge needle. Label indicates use for intravenous cardiac arrhythmias. Manufactured by Hospira, Inc., with instructions for aseptic technique and administration.*

FDA Label Image

Principal Display Panel (20 mg/mL Syringe Label)

The label displays Lidocaine Hydrochloride Injection USP with a strength of 2% (100 mg/5 mL or 20 mg/mL) in a 5 mL single-dose syringe. It is intended for intravenous use for ventricular arrhythmias and is distributed by Hospira, Inc. The label includes dosing gradations, lot number, and expiration date fields.*

FDA Label Image

Principal Display Panel (20 mg/mL Syringe Carton)

Packaging label for Lidocaine Hydrochloride Injection, USP 2%, 20 mg/mL strength in a 5 mL single-dose syringe. The label indicates a total of 100 mg per syringe, preservative-free formulation, distributed by Hospira, Inc. Instructions for aseptic technique use are illustrated. The product is labeled for intravenous use for ventricular arrhythmias.*

FDA Label Image

Principal Display Panel (10 mg/mL Syringe Label)

Label for Hospira, Inc. 1% Lidocaine Hydrochloride Injection, USP, 50 mg/5 mL (10 mg/mL) in a 5 mL single-dose syringe. The label includes dosing marks, NDC 0409-9137-11, and states intravenous use for ventricular arrhythmias with pH between 5.0 to 7.0. Lot and expiration date placeholders are also shown.*

FDA Label Image

Principal Display Panel (10 mg/mL Syringe Carton)

Label for Lidocaine Hydrochloride Injection, USP 1% (50 mg/5 mL or 10 mg/mL) single-dose syringe by Hospira, Inc. The 5 mL syringe contains 50 mg total lidocaine HCl, preservative-free, for intravenous use in ventricular arrhythmias. The label includes directions for aseptic technique, storage info, and manufacturing details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.